An Open, Single-arm, Multicenter, Prospective Phase II Study of Fuquinitinib Combined With Tegafur Gimeracil Oteracil in the Third-line Treatment of Patients With Advanced Metastatic CRC

Conditions: Metastasis Colorectal Cancer; Colon Cancer; Rectal Cancer Interventions: Drug: Fuquinitinib+Tegafur Gimeracil Oteracil Sponsors: Guangzhou University of Traditional Chinese Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials